PI3K/Akt Pathway: A Potential Therapeutic Target for Chronic Pain
Shuping Chen(Chinese Academy of Medical Sciences & Peking Union Medical College), Deeq Mohamed Omar(Huazhong University of Science and Technology), Anne Manyande(University of West London), Dai-Qiang Liu(Tongji Hospital), Wen Zhang(Xidian University), Yuke Tian(Tongji Hospital), Xuehai Guan(First Affiliated Hospital of GuangXi Medical University), Dawei Ye(Tongji Hospital), Ya‐Qun Zhou(Tongji Hospital)
Cited by 126
Related Papers
Interleukin-6: an emerging regulator of pathological pain
|Journal of Neuroinflammation|2016|438
Non-pharmacological interventions for assisting the induction of anaesthesia in children
|Cochrane Database of Systematic Reviews|2015|329
Carbon Monoxide and Its Controlled Release: Therapeutic Application, Detection, and Development of Carbon Monoxide Releasing Molecules (CORMs)
|Journal of Medicinal Chemistry|2017|316
Targeting JAK-STAT Signaling to Control Cytokine Release Syndrome in COVID-19
|Trends in Pharmacological Sciences|2020|304
The comprehensive study on the therapeutic effects of baicalein for the treatment of COVID-19 in vivo and in vitro
|Biochemical Pharmacology|2020|160